As a Senior Scientist in Assay Development at BellBrook Labs, I specialize in developing and optimizing biochemical and cellular assays for many therapeutic enzymes, with a focus on the innate immune and DNA damage repair pathways. I characterize assays in various formats, including FP, FI, TR-FRET, Alphalisa, Luminescence, and colorimetric. Additionally, I involved in a drug discovery program for Trex1, a key enzyme in immune regulation and cancer. My expertise encompasses enzymology, high-throughput screening, hit triage and validation, and more.Prior to joining BellBrook Labs, I completed my PhD in Biochemistry at the University of Illinois at Chicago, where I designed a versatile toolkit to accelerate the generation of high dynamic-range FRET biosensors for microscopic imaging and cell-based assays. During my postdoctoral work, I primarily focused on engineering protein tools to elucidate the function of cellular lipids. Through these experiences, I have acquired skills in molecular cloning, protein expression, western blotting, cell culture, microscopy, and microinjection.My passion lies in creating biochemical tools that can advance drug discovery and fundamental research, and in collaborating with other scientists and stakeholders to translate scientific insights into practical solutions.